Comprehensive panels - Insights
Check out Mayo Clinic Laboratories’ comprehensive pharmacogenomic panels, which identify genetic variations associated with treatment response.
Purine and pyrimidine metabolism disorders - Insights
Check out how Mayo Clinic Laboratories’ genetic testing can help to diagnose and monitor patients affected by purine and pyrimidine metabolism disorders.
Advanced Phlebotomy Collections - Insights
Find out about advanced blood collection techniques and the specialized procedures that are used when standard blood collection methods may not be feasible or when specific tests require more specialized handling of blood samples.
Safety in Phlebotomy - Insights
Get a general introduction to safety precautions, which will help ensure the well-being of you and your patients.
Specimen Integrity and Processing - Insights
Learn about the variables influencing successful blood draws and their potential impact on laboratory outcomes, Quality Assurance principles, the regulatory agencies ensuring patient and healthcare worker safety, and the organizational...
Difficult Collections and Special Populations - Insights
Get an overview of phlebotomy techniques for pediatric and geriatric patients who often present as unique challenges due to their physiological and anatomical differences.
Neuromuscular panel - Insights
Find out how the emergence of advanced molecular testing technologies has enhanced the detection of inherited neuromuscular disorders.
Other neuromuscular disorders - Insights
Learn how our comprehensive menu of focused panels can provide clarity and confidence when diagnosing neuromuscular disorders.
Frontotemporal dementia and ALS - Insights
Learn more about how detection of amyotrophic lateral sclerosis and frontotemporal dementia paved the way for gene-targeted therapies for patients.
In vitro diagnostics solutions - Insights
BioPharma Diagnostics supports medical device, biopharma, and diagnostic companies with in vitro diagnostic services, including analytical validation of new assays and devices in compliance with CAP/CLIA requirements.